We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
You may automatically receive Enzon Pharmaceuticals Inc. financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
Company continues to progress as an innovative oncology
development company
--Company is transformed to be exclusively focused on its pipeline--
